Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
|
Gastroenterology
|
2008
|
15.86
|
2
|
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
|
CA Cancer J Clin
|
2008
|
12.90
|
3
|
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.
|
Gastroenterology
|
2012
|
8.51
|
4
|
Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.
|
Science
|
2003
|
6.85
|
5
|
Prediction of germline mutations and cancer risk in the Lynch syndrome.
|
JAMA
|
2006
|
4.34
|
6
|
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.
|
Clin Gastroenterol Hepatol
|
2006
|
4.22
|
7
|
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome.
|
Clin Cancer Res
|
2006
|
3.81
|
8
|
Small changes in expression affect predisposition to tumorigenesis.
|
Nat Genet
|
2001
|
3.37
|
9
|
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
|
Clin Gastroenterol Hepatol
|
2004
|
3.10
|
10
|
Aberrant crypt foci in the adenoma prevention with celecoxib trial.
|
Cancer Prev Res (Phila)
|
2008
|
2.47
|
11
|
NCCN clinical practice guidelines in oncology. Colorectal cancer screening.
|
J Natl Compr Canc Netw
|
2010
|
2.13
|
12
|
Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition.
|
Gastroenterology
|
2004
|
2.06
|
13
|
Impact of genetic counseling and testing on colorectal cancer screening behavior.
|
Genet Test
|
2002
|
1.81
|
14
|
High incidence of microsatellite instability in colorectal cancer from African Americans.
|
Clin Cancer Res
|
2003
|
1.68
|
15
|
Risk of colorectal cancer in juvenile polyposis.
|
Gut
|
2007
|
1.64
|
16
|
Relative frequency and morphology of cancers in STK11 mutation carriers.
|
Gastroenterology
|
2004
|
1.62
|
17
|
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.
|
Clin Gastroenterol Hepatol
|
2006
|
1.57
|
18
|
Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.
|
Gastroenterology
|
2002
|
1.45
|
19
|
Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients.
|
Genet Med
|
2004
|
1.39
|
20
|
Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study.
|
Clin Gastroenterol Hepatol
|
2008
|
1.32
|
21
|
Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.
|
Int J Cancer
|
2005
|
1.26
|
22
|
Juvenile polyposis syndrome.
|
World J Gastroenterol
|
2011
|
1.26
|
23
|
Familial adenomatous polyposis.
|
Gastrointest Endosc
|
2003
|
1.22
|
24
|
Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
|
Clin Cancer Res
|
2005
|
1.21
|
25
|
Gastrointestinal polyposis syndromes.
|
Curr Mol Med
|
2007
|
1.18
|
26
|
Chemoprevention in familial adenomatous polyposis.
|
Best Pract Res Clin Gastroenterol
|
2011
|
1.17
|
27
|
Genetic testing for hereditary colorectal cancer in children: long-term psychological effects.
|
Am J Med Genet A
|
2003
|
1.15
|
28
|
Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
|
J Natl Compr Canc Netw
|
2016
|
1.12
|
29
|
Chemoprevention strategies using NSAIDs and COX-2 inhibitors.
|
Cancer Biol Ther
|
2003
|
1.11
|
30
|
Rapid development of colorectal neoplasia in patients with Lynch syndrome.
|
Clin Gastroenterol Hepatol
|
2010
|
1.11
|
31
|
Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms.
|
Am J Surg Pathol
|
2014
|
1.09
|
32
|
SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome.
|
Clin Cancer Res
|
2010
|
1.08
|
33
|
Serrated polyposis: rapid and relentless development of colorectal neoplasia.
|
Gut
|
2012
|
1.07
|
34
|
Colorectal cancer screening.
|
J Natl Compr Canc Netw
|
2013
|
1.02
|
35
|
Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.97
|
36
|
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer.
|
Gastrointest Endosc
|
2014
|
0.94
|
37
|
Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
|
Epigenetics
|
2009
|
0.91
|
38
|
Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
|
Cancer Biol Ther
|
2007
|
0.91
|
39
|
Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas.
|
Clin Cancer Res
|
2003
|
0.90
|
40
|
Multiple colorectal neoplasms in X-linked agammaglobulinemia.
|
Clin Gastroenterol Hepatol
|
2007
|
0.90
|
41
|
Diagnosis and management of hereditary colon cancer.
|
Gastroenterol Clin North Am
|
2002
|
0.90
|
42
|
A new phenotypic manifestation of familial adenomatous polyposis.
|
Fam Cancer
|
2011
|
0.87
|
43
|
Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.87
|
44
|
Patient preferences regarding recontact by cancer genetics clinicians.
|
Fam Cancer
|
2007
|
0.86
|
45
|
Colorectal Cancer Screening Clinical Practice Guidelines.
|
J Natl Compr Canc Netw
|
2006
|
0.86
|
46
|
Molecular genetic evidence of an association between nasal polyposis and the Peutz-Jeghers syndrome.
|
Ann Intern Med
|
2002
|
0.85
|
47
|
Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.
|
Clin Cancer Res
|
2004
|
0.85
|
48
|
Nasal polyposis in Peutz-Jeghers syndrome: a distinct histopathological and molecular genetic entity.
|
J Clin Pathol
|
2006
|
0.83
|
49
|
Upper tract juvenile polyps in juvenile polyposis patients: dysplasia and malignancy are associated with foveolar, intestinal, and pyloric differentiation.
|
Am J Surg Pathol
|
2014
|
0.82
|
50
|
Refractory lymphocytic enterocolitis and tumor necrosis factor antagonist therapy.
|
Clin Gastroenterol Hepatol
|
2009
|
0.82
|
51
|
The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation.
|
Cancer Causes Control
|
2014
|
0.81
|
52
|
Histologic variations in juvenile polyp phenotype correlate with genetic defect underlying juvenile polyposis.
|
Am J Surg Pathol
|
2011
|
0.81
|
53
|
Increased cyclooxygenase-2 expression in juvenile polyposis syndrome.
|
Clin Gastroenterol Hepatol
|
2008
|
0.81
|
54
|
Aberrant intestinal stem cell lineage dynamics in Peutz-Jeghers syndrome and familial adenomatous polyposis consistent with protracted clonal evolution in the crypt.
|
Gut
|
2011
|
0.80
|
55
|
Shiga toxin is transported into the nucleoli of intestinal epithelial cells via a carrier-dependent process.
|
Toxins (Basel)
|
2010
|
0.79
|
56
|
LKB1 as the ghostwriter of crypt history.
|
Fam Cancer
|
2011
|
0.79
|
57
|
Positive correlation of insulin-like growth factor-II with proliferating cell index in patients with colorectal neoplasia.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.79
|
58
|
Do people know whether they are overweight? Concordance of self-reported, interviewer-observed, and measured body size.
|
Cancer Causes Control
|
2014
|
0.78
|
59
|
Rectal epithelial apoptosis does not predict response to sulindac treatment or polyp development in presymptomatic familial adenomatous polyposis patients.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
0.76
|
60
|
Clinical Characteristics of Multiple Colorectal Adenoma Patients Without Germline APC or MYH Mutations.
|
J Clin Gastroenterol
|
2016
|
0.76
|
61
|
Sporadic duodenal adenoma and association with colorectal neoplasia: a case-control study.
|
Dig Dis Sci
|
2014
|
0.76
|
62
|
Familial colorectal cancer screening: so close, so far.
|
Gastroenterology
|
2013
|
0.75
|
63
|
Detection of familial adenomatous polyposis with orthogonal polarized spectroscopy of the oral mucosa vasculature.
|
J Biophotonics
|
2011
|
0.75
|
64
|
Biographical sketch of Jan Peutz.
|
Gastroenterology
|
2008
|
0.75
|